Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: memo - Magazine of European Medical Oncology 3/2019

01.07.2019 | short review

Skin tumours in organ transplant recipients—implications for the plastic surgeon

verfasst von: M.D. Johanna Krapf, M.D. Gerhard Pierer

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Squamous cell carcinoma of the skin (SCC) and basal cell carcinoma (BCC) are common entities, often with a benign course. Tumour biology, however, is different in immunosuppressed individuals, such as organ transplant recipients (OTR). As immunosuppression-sparing protocols have not yet been successfully introduced to the clinics, nonmelanoma skin cancers (NMSCs) will continue to affect a majority of OTR, leading to significant morbidity and mortality. Interdisciplinary treatment including the transplant physician, dermatologist and the plastic surgeon is warranted for optimal patient management. This review focuses on special tumour characteristics and therapeutic requirements among OTR. Recommendations for local treatment and oncoplastic surgery are discussed.
Literatur
1.
Zurück zum Zitat Kim R, Armstrong A. Non-melanoma skin cancer. Dermatol Clin. 2012;30:125–39. CrossRef Kim R, Armstrong A. Non-melanoma skin cancer. Dermatol Clin. 2012;30:125–39. CrossRef
2.
Zurück zum Zitat Mittal A, Colegio O. Skin cancers in organ transplant recipients. Am J Transpl. 2017;17:2509–30. CrossRef Mittal A, Colegio O. Skin cancers in organ transplant recipients. Am J Transpl. 2017;17:2509–30. CrossRef
3.
Zurück zum Zitat Greenberg J, Zwald F. Management of skin cancer in solid organ transplant recipients: a multidisciplinary approach. Dermatol Clin. 2011;29:231–41. CrossRef Greenberg J, Zwald F. Management of skin cancer in solid organ transplant recipients: a multidisciplinary approach. Dermatol Clin. 2011;29:231–41. CrossRef
4.
Zurück zum Zitat Thompson A, Kelley B, Prokop L, et al. Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis. Jama Dermatol. 2016;152:419–28. CrossRef Thompson A, Kelley B, Prokop L, et al. Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis. Jama Dermatol. 2016;152:419–28. CrossRef
5.
Zurück zum Zitat Brantsch K, Meisner C, Schonfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9:713–20. CrossRef Brantsch K, Meisner C, Schonfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9:713–20. CrossRef
6.
Zurück zum Zitat Acuna S, Fernandes K, Daly C, et al. Cancer mortality among recipients of solid-organ transplantation in Ontario, Canada. Jama Oncol. 2016;2(4):463–9. CrossRef Acuna S, Fernandes K, Daly C, et al. Cancer mortality among recipients of solid-organ transplantation in Ontario, Canada. Jama Oncol. 2016;2(4):463–9. CrossRef
7.
Zurück zum Zitat Terhorst D, Drecoll U, Stockfleth E, et al. Organ transplant recipients and skin cancer: assessment of risk factors with focus on sun exposure. Br J Dermatol. 2009;161(Suppl. 3):85–9. CrossRef Terhorst D, Drecoll U, Stockfleth E, et al. Organ transplant recipients and skin cancer: assessment of risk factors with focus on sun exposure. Br J Dermatol. 2009;161(Suppl. 3):85–9. CrossRef
8.
Zurück zum Zitat O’Donovan P, Perret C, Zhang X, et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science. 2005;309:1871–4. CrossRef O’Donovan P, Perret C, Zhang X, et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science. 2005;309:1871–4. CrossRef
9.
Zurück zum Zitat Ulrich C, Jurgensen J, Degen A, et al. Prevention of nonmelanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24-month, prospective, case–control study. Br J Dermatol. 2009;161(Suppl. 3):78–84. CrossRef Ulrich C, Jurgensen J, Degen A, et al. Prevention of nonmelanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24-month, prospective, case–control study. Br J Dermatol. 2009;161(Suppl. 3):78–84. CrossRef
10.
Zurück zum Zitat Reichrath J, Nurnberg B. Solar UV-radiation, vitamin D and skin cancer surveillance in organ transplant recipients (OTRs). Adv Exp Med Biol. 2008;624:203–14. CrossRef Reichrath J, Nurnberg B. Solar UV-radiation, vitamin D and skin cancer surveillance in organ transplant recipients (OTRs). Adv Exp Med Biol. 2008;624:203–14. CrossRef
11.
Zurück zum Zitat Euvrard S, Morelon E, Rostaing L, et al. Sirolimus and secondary skin cancer prevention in kidney transplantation. N Engl J Med. 2012;367:329–39. CrossRef Euvrard S, Morelon E, Rostaing L, et al. Sirolimus and secondary skin cancer prevention in kidney transplantation. N Engl J Med. 2012;367:329–39. CrossRef
12.
Zurück zum Zitat Chen A, Martin A, Choy B, et al. A phase 3 randomized trial of Nicotinamide for skin-cancer chemoprevention. N Engl J Med. 2015;373:1618–26. CrossRef Chen A, Martin A, Choy B, et al. A phase 3 randomized trial of Nicotinamide for skin-cancer chemoprevention. N Engl J Med. 2015;373:1618–26. CrossRef
13.
Zurück zum Zitat Drago F, Ciccarese G, Cogorno L, et al. Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study. Eur J Dermatol. 2017;27:382–5. PubMed Drago F, Ciccarese G, Cogorno L, et al. Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study. Eur J Dermatol. 2017;27:382–5. PubMed
14.
Zurück zum Zitat Veness M, Palme C, Morgan G. High-risk squamous cell carcinoma of the head and neck. Results from 266 treated patients with metastatic lymph node disease. Cancer. 2006;23:2389–96. CrossRef Veness M, Palme C, Morgan G. High-risk squamous cell carcinoma of the head and neck. Results from 266 treated patients with metastatic lymph node disease. Cancer. 2006;23:2389–96. CrossRef
15.
Zurück zum Zitat Padhya T, Cornelius R, Athavale S, et al. Perineural extension to the skull base from early cutaneous malignancies of the midface. Otolaryngol Head Neck Surg. 2007;137:742–6. CrossRef Padhya T, Cornelius R, Athavale S, et al. Perineural extension to the skull base from early cutaneous malignancies of the midface. Otolaryngol Head Neck Surg. 2007;137:742–6. CrossRef
16.
Zurück zum Zitat Leibovitch I, Huilgol S, Selva D, et al. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia II. Perineural invasion. J Am Acad Dermatol. 2005;53:261–6. CrossRef Leibovitch I, Huilgol S, Selva D, et al. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia II. Perineural invasion. J Am Acad Dermatol. 2005;53:261–6. CrossRef
17.
Zurück zum Zitat Nahhas A, Scarbrough C, Trotter S, et al. A review of the global guidelines on surgical margins for nonmelanoma skin cancers. J Clin Aesthet Dermatol. 2017;10(4):37–46. PubMedPubMedCentral Nahhas A, Scarbrough C, Trotter S, et al. A review of the global guidelines on surgical margins for nonmelanoma skin cancers. J Clin Aesthet Dermatol. 2017;10(4):37–46. PubMedPubMedCentral
19.
Zurück zum Zitat Sterry W, European Dermatology Forum Guideline Committee. Guidelines: The management of basal cell carcinoma. Eur J Dermatol. 2006;16(5):467–75. Sterry W, European Dermatology Forum Guideline Committee. Guidelines: The management of basal cell carcinoma. Eur J Dermatol. 2006;16(5):467–75.
20.
Zurück zum Zitat Wagner JD, Evdokimow DZ, Weisberger E, et al. Sentinel lymph node biopsy for high-risk nonmelanoma cutaneous malignancy. Arch Dermatol. 2004;140:75–9. CrossRef Wagner JD, Evdokimow DZ, Weisberger E, et al. Sentinel lymph node biopsy for high-risk nonmelanoma cutaneous malignancy. Arch Dermatol. 2004;140:75–9. CrossRef
21.
Zurück zum Zitat Ward D, London N, Collar R. Role of secondary intention healing. Facial Plast Surg. 2013;29(05):346–50. CrossRef Ward D, London N, Collar R. Role of secondary intention healing. Facial Plast Surg. 2013;29(05):346–50. CrossRef
22.
Zurück zum Zitat Roine E, Bjork I, Oyen O, et al. Targeting risk factors for impaired wound healing and wound complications after kidney transplantation. Transplant Proc. 2010;42(7):2542–6. CrossRef Roine E, Bjork I, Oyen O, et al. Targeting risk factors for impaired wound healing and wound complications after kidney transplantation. Transplant Proc. 2010;42(7):2542–6. CrossRef
23.
Zurück zum Zitat Veness M, Porceddu S, Palme C, et al. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck. 2007;29:621–31. CrossRef Veness M, Porceddu S, Palme C, et al. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck. 2007;29:621–31. CrossRef
Metadaten
Titel
Skin tumours in organ transplant recipients—implications for the plastic surgeon
verfasst von
M.D. Johanna Krapf
M.D. Gerhard Pierer
Publikationsdatum
01.07.2019
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 3/2019
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-019-0504-7